Live Breaking News & Updates on As Anvs Us03615a1088

Stay updated with breaking news from As anvs us03615a1088. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

ANNOVIS BIO RAISES AGGREGATE GROSS PROCEEDS OF APPROXIMATELY $8.7 MILLION

BERWYN, Pa., April 11, 2023 /PRNewswire/ Annovis Bio, Inc. , a clinical-stage drug platform company addressing neurodegenerative diseases, today announced that in the last week it has raised. | April 11, 2023 ....

United States , Annovis Bio , Chris Calabrese , Nic Johnson , Kevin Gardner , Bio Inc , Lifesci Advisors , Russo Partners , Company Annual Report On Form , Annovis Bio Inc , Bofa Securities Inc , Securities Exchange , Equity Offering Sales Agreement , Bofa Securities , Securities Act , Securities Exchange Act , Annual Report , Quarterly Reports , Sci Advisors , Nc Stock Exchange , Press Release , As Anvs Us03615a1088 ,

Annovis Bio Appoints Henry Hagopian III as Chief Financial Officer

BERWYN, Pa., Aug. 29, 2022 /PRNewswire/ Annovis Bio, Inc. , a clinical-stage drug platform company addressing neurodegenerative diseases, announced the appointment of Henry Hagopian III as Chief. | August 29, 2022 ....

United States , Marial Maccecchini , Nic Johnson , Annovis Bio , Jeff Mcgroarty , Exchange Commission , Prnewswire Annovis Bio Inc , Annovis Bio Inc , Russo Partners , Henry Hagopian , Chief Financial Officer , Senior Vice President , Chief Financial , Carroll Graduate School , Boston College , Silberman College , Farleigh Dickinson , Annual Report , Investor Contact , Nc Stock Exchange , Press Release , As Anvs Us03615a1088 ,